Home

Religare Enterprises Ltd (RELIGAREEN)

NSE/BSE · Financial Services · Diversified Financials

Religare Enterprises has staged a significant revenue recovery after a period of distress between FY2018-FY2021. Revenue has grown from ₹2,371 Cr in FY2019 to ₹7,385 Cr in FY2025, more than tripling over six years. The company's turnaround is largely driven by its health insurance subsidiary (Care Health) and the broader financial services recovery.

Key Metrics

About This Report

This research was independently produced by 3 AI models analyzing the same underlying data. Each model read the company's annual reports, earnings transcripts, financial statements, and external research – then formed its own conclusions.

Sections

Business – How the business works, competitive positioning, key metrics

Numbers – Financials, valuation, cash generation, peer comparison

People – Management, governance, compensation, alignment

Story – Narrative evolution, credibility, risk history

Verdict – Catalysts, buy/hold/sell decision, scenarios